Concepedia

Janet Woodcock

JW

Statistics

Publications

81

Citations

11.2K

H-Index

42

Active since

1982

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Center for Biologics Evaluation and Research

Massachusetts Institute of Technology

Janet Woodcock is an author at Center for Drug Evaluation and Research specializing in medicine, health policy, and pharmacology.

Top concepts

MedicinePharmacologyHealth PolicyPublic HealthDrug DiscoveryPharmacotherapyHealthPatient SafetyClinical TrialsDrug Development

Publications per year

1982–2023

81

Publications

81

Real-World Evidence — What Is It and What Can It Tell Us?

Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan et al. · New England Journal of Medicine · 2016 · 1.9K citations

Healthcare Monitoring Systems, Engineering, Ehr Systems +24

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock, Lisa M. LaVange · New England Journal of Medicine · 2017 · 926 citations · Full text

Master Protocols, Disease Management, Preventive Medicine +8

Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

Sau L. Lee, Thomas O’Connor, Xiaochuan Yang et al. · Journal of Pharmaceutical Innovation · 2015 · 832 citations · Full text

Pharmaceutical Formulation, Industrial Design, Pharmaceutical Supply Chain +5

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 613 citations · Full text

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 612 citations

Chondroitin Sulfate, Adverse Clinical Events, Pharmacology +4

Rows per page

1–5 of 81